BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 2015
View Archived Issues
AmorChem licenses mucoadhesive nanoparticle technology from University of Waterloo
Read More
JDRF supports Janssen's disease interception approach to prevent onset of type 1 diabetes
Read More
Cidara Therapeutics completes financing round to support pipeline
Read More
Cipla's U.K. subsidiary enters into a joint venture with Cooper Pharma and PHI
Read More
DARPA awards contract to SRI Biosciences to discover synthetic polymer drugs
Read More
Novigenix acquires colon cancer blood test Colox
Read More
AC Immune receives MJFF grant to develop PET tracer for Parkinson's disease diagnosis
Read More
Clinigen opens global access program for ceftazidime/avibactam
Read More
Epitarget and IC Contrast complete merger
Read More
Promising data revealed on a novel Ebola vaccine candidate
Read More
Novavax begins phase I Ebola vaccine trial
Read More
Horizon Pharma submits IND application for Actimmune for Friedreich's ataxia
Read More
Shanghai Institute Materia Medica discloses new alpha1A-adrenoreceptor antagonists
Read More
Vernalis and Servier patent novel Bcl-2 inhibitors
Read More
Novartis reports new apelin receptor agonists
Read More
New FXIa inhibitors designed by Bayer
Read More
Capsule depolymerase EnvD shows efficacy in an inhalation model of anthrax
Read More
Scientists at Instituto Italiano di Tecnologia disclose FAAH inhibitors
Read More
FDA approves lenvatinib for thyroid cancer
Read More
First in vivo results presented of novel ricin and Shigatoxin trafficking inhibitors
Read More
Lassa fever recombinant vaccine shows enhanced immunogenicity in mice
Read More
FDA accepts NDA for Pfizer's abuse-deterrent formulation of oxycodone
Read More
FDA approves sNDA for rufinamide in Lennox-Gastaut syndrome in children aged 1-4 years
Read More
Novartis's LCZ-696 to receive FDA priority review for heart failure
Read More
N9-GP shows efficacy in pediatric hemophilia B patients
Read More